A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas

Targeted therapy is lagging behind in esophageal adenocarcinoma (EAC). To guide the development of new treatment strategies, we provide an overview of the prognostic biomarkers in resectable EAC treated with curative intent. The Medline, Cochrane and EMBASE databases were systematically searched, fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Creemers, Aafke, Ebbing, Eva A., Pelgrim, Thomas C., Lagarde, Sjoerd M., van Etten-Jamaludin, Faridi S., van Berge Henegouwen, Mark I., Hulshof, Maarten C. C. M., Krishnadath, Kausilia K., Meijer, Sybren L., Bijlsma, Maarten F., van Oijen, Martijn G. H., van Laarhoven, Hanneke W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125467/
https://www.ncbi.nlm.nih.gov/pubmed/30185893
http://dx.doi.org/10.1038/s41598-018-31548-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125467/
https://www.ncbi.nlm.nih.gov/pubmed/30185893
http://dx.doi.org/10.1038/s41598-018-31548-6

Ejemplares similares